{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:22:57Z","timestamp":1791364977909,"version":"4.3.1"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background\/Aims<\/jats:title>\n                    <jats:p>Central precocious puberty (CPP) is due to premature activation of the hypothalamic-pituitary-gonadal axis. It predominantly affects girls. CPP leads to lower final height (FH), yet the treatment benefit in girls between 6 and 8 years is equivocal. Our main goal was to evaluate the effects of gonadotropin-releasing hormone analog (GnRHa) on FH and identify factors that predict FH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a retrospective study, children with CPP (12 boys, 81 girls) that reached FH were included. Their clinical data at diagnosis and up to their final height was compared by descriptive statistics among idiopathic (iCPP) (n=68) and non-idiopathic CPP (nCPP) and between GnRHa treated (n=48) and untreated (n=15) girls with iCPP. The treatment effect of body weight (BW) adjusted GnRHa dosing was evaluated. Univariate linear regression and step-wise multivariable regression including 48 girls with iCPP treated with GnRHa were performed to identify predicting factors for FH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Children with idiopathic CPP (iCPP) reached higher FH (p=0.002) than children with non-idiopathic CPP. After the diagnosis, the treated group gained 7.0\u00a0cm more than the untreated group. Yet, attributable to individualized decision-making, the FH in both groups was comparable (161.5\u00a0cm in treated, 161.0\u00a0cm in untreated girls with iCPP), although the onset of menarche was 2.5 years earlier among untreated girls. BW-adjusted dosing suppressed peak luteinizing hormone (LH) below 4.5 IU\/L in 95% of children; however, bone age further advanced during therapy in 38% of patients. Predicting factors revealed by multivariable regression were bone age at diagnosis, BMI SDS at diagnosis, LH basal, age at start and cessation of treatment, predicted adult height and target height. (R2 = 0.72).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children with nCPP had worse FH outcome compared to iCPP despite similar CPP onset and therapeutic characteristics. Treatment by GnRHa using BW-adjusted dosing was effective in delaying menarche onset and reaching target height in girls with iCPP. Multiple factors affecting FH outcome indicated individualized decision-making regarding therapeutic intervention remains challenging. In the treated patients, among the factors that can be influenced, height at treatment cessation most significantly influenced the outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.1008474","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T05:10:58Z","timestamp":1669957858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Final adult height in children with central precocious puberty \u2013 a retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Taja","family":"Knific","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Lazarevi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janez","family":"\u017dibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Obolnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Aleksovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"\u0160uput Omladi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Avbelj Stefanija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-015-0130-8","article-title":"Central precocious puberty: Update on diagnosis and treatment","volume":"17","author":"Chen","year":"2015","journal-title":"Pediatr Drugs"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-8684-8_18","article-title":"Precocious puberty","author":"Carel","year":"2014","journal-title":"Endocrinol Diabetes A Probl Approach."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15665","article-title":"Trends in the incidence of central precocious puberty and normal variant puberty among children in Denmark, 1998 to 2017","volume":"3","author":"Br\u00e4uner","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0012","article-title":"Prevalence and incidence of precocious pubertal development in Denmark: An epidemiologic study based on national registries","volume":"116","author":"Teilmann","year":"2005","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/EJE-17-0379","article-title":"Marked geographic patterns in the incidence of idiopathic central precocious puberty: A nationwide study in France","volume":"178","author":"Le Moal","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: Incidence, prevalence, and influence of adoption and immigration","volume":"95","author":"Soriano-Guill\u00e9n","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0141844","article-title":"A significant increase in the incidence of central precocious puberty among Korean girls from 2004 to 2010","volume":"10","author":"Kim","year":"2015","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.12.022","article-title":"Incidence and prevalence of central precocious puberty in Korea: An epidemiologic study based on a national database","volume":"208","author":"Kim","year":"2019","journal-title":"J Pediatr [Internet]."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3079","article-title":"Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls","volume":"126","author":"Biro","year":"2010","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2015.12.002","article-title":"The evolution of the age at menarche from prehistorical to modern times","volume":"29","author":"Papadimitriou","year":"2016","journal-title":"J Pediatr Adolesc Gynecol [Internet]."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-020-00931-3","article-title":"Increased incidence of precocious and accelerated puberty in females during and after the Italian lockdown for the coronavirus 2019 (COVID-19) pandemic","volume":"46","author":"Stagi","year":"2020","journal-title":"Ital J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000336325","article-title":"Recent secular trends in pubertal timing: Implications for evaluation and diagnosis of precocious puberty","volume":"77","author":"S\u00f8rensen","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00380-0","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","journal-title":"Lancet Diabetes Endocrinol [Internet]."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.156","article-title":"The role of estrogen receptor \u03b1 in growth plate cartilage for longitudinal bone growth","volume":"25","author":"B\u00f6rjesson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2000.13.S1.723","article-title":"Pharmacokinetics and pharmacodynamics of GnRH agonists: Clinical implications in pediatrics","volume":"13","author":"Lahlou","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04022-1","article-title":"Diagnosis and management of precocious sexual maturation: an updated review","volume":"180","author":"Cheuiche","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000212","article-title":"Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment","volume":"64","author":"Bideci","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: Update by an international consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S0004-27302008000100005","article-title":"Update on the etiology , diagnosis and therapeutic revis\u00e3o","volume":"52","author":"Brito","year":"2008","journal-title":"Arq Bras Endrocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13633-017-0046-x","article-title":"Appraisal of testicular volumes: volumes matching ultrasound values referenced to stages of genital development","volume":"2017","author":"Sotos","year":"2017","journal-title":"Int J Pediatr Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/adc.45.244.755","article-title":"Standards for children\u2019s height at ages 2-9 years allowing for height of parents","volume":"45","author":"Tanner","year":"1970","journal-title":"Arch Dis Child."},{"key":"B23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1109\/TMI.2008.926067","article-title":"The BoneXpert method for automated determination of skeletal maturity","volume":"28","author":"Thodberg","year":"2009","journal-title":"IEEE Trans Med Imaging."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/adc.73.1.17","article-title":"Cross sectional stature and weight reference curves for the UK, 1990","volume":"73","author":"Freeman","year":"1995","journal-title":"Arch Dis Child"},{"key":"B25","first-page":"45\u201460","article-title":"The LMS method for constructing normalized growth standards","volume":"44","author":"Cole","year":"1990","journal-title":"Eur J Clin Nutr [Internet]."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15690","article-title":"Accuracy and consequences of reported target height","volume":"110","author":"Ceconi","year":"2021","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04185.x","article-title":"Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection","volume":"76","author":"Demirbilek","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1500","article-title":"Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty","volume":"91","author":"Badaru","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2013-20","article-title":"Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy","volume":"2013","author":"Neely","year":"2013","journal-title":"Int J Pediatr Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1157\/13094248","article-title":"El Tratamiento con triptorelina en las ni\u00f1as con pubertad precoz central provoca incremento del \u00edndice de masa corporal","volume":"65","author":"Mart\u00edn D\u00edaz","year":"2006","journal-title":"Pediatr [Internet]."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12964","article-title":"Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: Presentation and long-term outcomes","volume":"84","author":"Chemaitilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000477584","article-title":"Long-term outcomes of patients with central precocious puberty due to hypothalamic hamartoma after GnRHa treatment: Anthropometric, metabolic, and reproductive aspects","volume":"106","author":"Ramos","year":"2018","journal-title":"Neuroendocrinology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02582.x","article-title":"Presentation and evolution of organic central precocious puberty according to the type of CNS lesion","volume":"65","author":"Trivin","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14198","article-title":"Endocrine manifestations in children with williams\u2013beuren syndrome","volume":"107","author":"Levy-Shraga","year":"2018","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2007.20.12.1333","article-title":"Precocious puberty in a girl with floating-harbor syndrome","volume":"20","author":"Stagi","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2022.2054048","article-title":"Van wyk-grumbach syndrome and trisomy 21","volume":"35","author":"Rivera-Hern\u00e1ndez","year":"2022","journal-title":"Baylor Univ Med Cent Proc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5533","article-title":"Editorial: Precocious puberty: Who has it? who should be treated","volume":"84","author":"Klein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update."},{"key":"B39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/jcrpe.2017.S004","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0321","article-title":"Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity","volume":"92","author":"Lazar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000491103","article-title":"Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty","volume":"90","author":"Kaplowitz","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2040268.134","article-title":"Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty","volume":"26","author":"Cho","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4274\/jcrpe.galenos.2019.2019.0060","article-title":"Treatment with depot leuprolide acetate in girls with idiopathic precocious puberty: What parameter should be used in deciding on the initial dose","volume":"12","author":"Vurall\u0131","year":"2020","journal-title":"JCRPE J Clin Res Pediatr Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.38.369","article-title":"A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty","volume":"38","author":"Tanaka","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5647","article-title":"Final height after long-term treatment with triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8481","article-title":"Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height","volume":"87","author":"Lazar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-200008000-00020","article-title":"Management of central isosexual precocity: Diagnosis, treatment, outcome","volume":"12","author":"Lebrethon","year":"2000","journal-title":"Curr Opin Pediatr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/humupd\/7.3.292","article-title":"Pathogenesis and epidemiology of precocious puberty. effects of exogenous oestrogens","volume":"7","author":"Partsch","year":"2001","journal-title":"Hum Reprod Update."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000231994","article-title":"Growth outcome during gnrh agonist treatments for slowly progressive central precocious puberty","volume":"90","author":"Massart","year":"2009","journal-title":"Neuroendocrinology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500533","article-title":"Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty","volume":"150","author":"Arrigo","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2022.02.004","article-title":"Growth variations with opposite clinical outcomes and the emerging role of IGF-1","volume":"33","author":"Papadimitriou","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1079\/PNS19940015","article-title":"The right weight: body fat, menarche and fertility","volume":"53","author":"Frisch","year":"1994","journal-title":"Proc Nutr Soc"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02695-0","article-title":"Study of xbal and pvull polymorphisms of estrogen receptor alpha (ER\u03b1) gene in girls with precocious\/early puberty","volume":"73","author":"Theodoropoulou","year":"2021","journal-title":"Endocrine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb12984.x","article-title":"Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatments","volume":"83","author":"Antoniazzi","year":"1994","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.4.292","article-title":"Final height in central precocious puberty after long term treatment with a slow release GnRH agonist","volume":"75","author":"Oostdijk","year":"1996","journal-title":"Arch Dis Child."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.12.6203","article-title":"Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function","volume":"84","author":"Heger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.109201","article-title":"Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment","volume":"137","author":"L\u00e9ger","year":"2000","journal-title":"J Pediatr"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2000.13.S1.747","article-title":"Treatment of central precocious puberty: Lessons from a 15 years prospective trial","volume":"13","author":"Partsch","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-2265.2002.01488.x","article-title":"Factors predicting adult height in girls with idiopathic central precocious puberty: Implications for treatment","volume":"56","author":"Adan","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: Impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2011-7","article-title":"Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): Growth outcomes during a prospective, longitudinal study","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.507289","article-title":"Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment","volume":"27","author":"Poomthavorn","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.01.021","article-title":"Time to menarche and final height after histrelin implant treatment for central precocious puberty","volume":"163","author":"Gillis","year":"2013","journal-title":"J Pediatr [Internet]."},{"key":"B64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.6065\/apem.2014.19.4.214","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone","volume":"19","author":"Jung","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2014-0305","article-title":"Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty","volume":"28","author":"Liang","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000441497","article-title":"Central precocious puberty: Adult height in girls treated with quarterly or monthly gonadotropin-releasing hormone analog triptorelin","volume":"84","author":"Bertelloni","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70221-0","article-title":"Bayley-pinneau method of height prediction in girls with central precocious puberty: Correlation with adult height","volume":"126","author":"Bar","year":"1995","journal-title":"J Pediatr"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.415","article-title":"Unsustained or slowly progressive puberty in young girls: Initial presentation and long-term follow-up of 20 untreated patients","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.2.8045957","article-title":"Adult height in girls precocious puberty","volume":"79","author":"Brauner","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.881794","article-title":"Predicting the adult height of girls with central precocious puberty","volume":"17","author":"Allali","year":"2011","journal-title":"Med Sci Monit"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.2.8045943","article-title":"Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty","volume":"79","author":"Kletter","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1159\/000053164","article-title":"Gonadotropin releasing hormone agonist treatment for central precocious puberty","volume":"51","author":"Carel","year":"1999","journal-title":"Horm Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0590","article-title":"Long-term outcomes of the treatment of central precocious puberty","volume":"174","author":"Guaraldi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2183","article-title":"Factors determining normal adult height in girls with gonadotropin- dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs","volume":"93","author":"Brito","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0243212","article-title":"Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty","volume":"15","author":"Shim","year":"2020","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1008474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T05:11:10Z","timestamp":1669957870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1008474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":75,"alternative-id":["10.3389\/fendo.2022.1008474"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1008474","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"article-number":"1008474"}}